医学会议分类导航
 
 
领域国际医学会议网公众号
 
首页  
2024年欧洲肺癌大会(ELCC)
     
 
 

◆ 会议时间:2024年3月20日至23日
◆ 会议地点:捷克 布拉格

 

◆ 会议简介:

2024年欧洲肺癌大会(ELCC2024)将于2024年3月20日至23日在捷克共和国布拉格举行,会议由欧洲肿瘤内科学会(ESMO)与国际肺癌研究协会(IASLC)联合组织。ELCC由代表胸部肿瘤专家的最重要的多学科学会联合协作举办,它们共同致力于促进科学发展、传播教育和提高全世界肺癌专家的实践。领域国际医学会议网;会议将回顾当前肺癌治疗的最新技术,更新您在预防、筛查、检测等方面的知识,与会者将从其全面而令人振奋的科学计划宣中受益。自2008年首次举办以来,ELCC已成为该领域专业人士的首要会议,大会与会者包括肿瘤内科医师、放射肿瘤学家、胸外科医生、呼吸内科医师/肺科医师、介入放射科医师、病理学家等众多专家学者。本次欧洲肺癌大会(ELCC)预计有超过2000名专业人士与会。

国际肺癌研究协会(IASLC)成立于1974年,是全球唯一致力于肺癌研究的组织,由致力于肺癌领域研究的专家们发起和创立,成员包括来自于全球100多个国家的5000多名肺癌专家。IASLC在肺癌和其他胸部恶性肿瘤的病因学、流行病学、预防、诊断、治疗以及与之相关的领域开展深入研究,为医学团体与大众服务。

欧洲肿瘤内科学会(ESMO)成立于1975年,是欧洲领先的肿瘤内科学专业组织,现在全球150多个国家和地区拥有超过17,000名会员,是肿瘤学教育和信息的参考学会,ESMO致力于支持其会员在快速发展的专业环境中得到发展与进步。作为一个非营利组织,ESMO一直以推动癌症护理和治疗为使命,致力于推进肿瘤医学专业的发展,以多学科的方法来促进癌症的治疗和护理。未经许可禁止复制摘录转载本站任何内容-国际医学会议网(lingyuint.com)。

European Lung Cancer Congress (ELCC 2024)
Date: 20-23 March, 2024
Venue: Prague Congress Centre, Prague, Czech Republic

 

We invite you to save the date for the European Lung Cancer Congress (ELCC 2024), taking place in Prague, Czech republic, from 20-23 March 2024. 

The European Lung Cancer Congress (ELCC 2024) is a collaborative effort of the most important multidisciplinary societies representing thoracic oncology specialists, working together to advance science, disseminate education and improve the practice of lung cancer specialists worldwide. 

Medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians / pneumologists, interventional radiologists and pathologists all benefit from its comprehensive and stimulating programme. 

Make sure you connect to this highly interactive meeting and share your expertise with lung cancer specialists from all over the world.  

 

摘要征文投稿:

Abstract submission deadlines

Deadline

Date and time

  • Abstract 
  • Trial in Progress
  • Intent to submit LBA

Tuesday, 9 January 2024, 21:00 CET (Central European Time)

  • Late-breaking abstracts (LBA)

Tuesday, 20 February 2024, 21:00 CET (Central European Time)

点此提交摘要>>>Submit Abstract>>>

提交指南>>>ELCC 2024 Abstract Regulations

 

Outcome notifications

Outcome notifications of regular abstracts are expected to be made available to first authors and submitters by end January.

Outcome notifications of accepted full LBAs are expected to be made available to first authors and submitters by end February.

Submission categories

  • Tumour biology and pathology
  • Translational research
  • Prevention, early detection, epidemiology, tobacco control
  • Imaging and staging
  • SCLC
  • Early stage NSCLC
  • Locally advanced NSCLC
  • Advanced NSCLC
  • Metastases to and from the lung
  • Mesothelioma
  • General interest

Late-breaking abstracts (LBA)

Late-breaking abstracts may be submitted for high quality, new research findings from randomised phase II or phase III trials with implications for clinical practice or understanding of disease processes.  

Only abstracts for which no conclusive data are available at the time of the abstract submission deadline of 9 January 2024 will be considered for late-breaking status. The work must not have been previously published in any publication in a peer review setting or presented at a meeting of any other scientific organisation prior to the ELCC 2024.

A skeleton indicating the type of data that will be available by the late-breaking abstract deadline must be submitted online by the regular abstract deadline on of Tuesday, 9 January 2024. 

Submitters of preliminary versions receiving approval to proceed must submit the final LBA by Tuesday, 20 February 2024. 

 

Trial in progress abstracts

Trial in Progress (TiP) abstracts in all phases of clinical research (phases I to III) may be submitted to ELCC 2024

It is expected that abstracts submitted as Trial in Progress are ongoing trials that have not reached any protocol-specified endpoints for analysis and consequently will only require the completion of two (2) sections:

  1. Background
  2. Trial design

Notes:

  • Recruitment must have already begun or have been completed by the abstract submission deadline of 9 January 2024.
  • Abstracts including results or preliminary data will be rejected.
  • Trial in Progress abstracts will not be considered for Proffered Paper (oral) presentation or Mini Oral.
  • Encore TiP abstracts will NOT be accepted. 

Publication schedule for accepted abstracts

Details regarding the publication of accepted abstracts will be available on this page in due time.

Details regarding ESMO PR activities will be made available 10 days prior to the Congress.

Embargo policy

Data and information included in accepted abstracts is under embargo until the relevant embargo release date cited in the schedule above.

Data and information beyond what is included in all accepted abstracts, for example full data sets, may only be made public at the start of the official programme session during which the study is presented.

Presentation and publication of accepted abstracts 

The ELCC 2024 Scientific Committee will select abstracts for presentation during the Congress based on the following possibilities:

  • Proffered Paper: Oral presentation of original data of superior quality, followed by expert discussion and perspectives
  • Mini Oral: Short oral presentation of good quality data, followed by expert discussion and perspectives.
  • Poster: Display session for review, discussion and questions. The presenting authors must be available for Q&A to represent their work.

All accepted abstracts will be published in the ELCC 2024 Abstract book, a supplement to the official ESMO journal, Annals of Oncology.

 

 


 

ELCC 2024 注册费:

In-person participation includes:

  • Participation in scientific and educational live sessions with the possibility to interact with the expert panel
  • Onsite networking opportunity with Faculty and peers
  • Entry to the Poster and e-Poster area
  • Interaction with the industry partners in the trade exhibition
  • Participation in the Industry Satellite Symposia
  • Access to the Virtual Platform to follow sessions live and/or view content on-demand*
  • Post-event resources
  • Coffee breaks

Online participation includes:

  • Access to the Virtual Platform, with live streaming of all sessions
  • Possibility to interact through the chat live discussion
  • Access to e-Posters
  • Entry to the Virtual Exhibition
  • Participation in the Industry Satellite Symposia
  • Post-event resources

Please be aware that until 28 February 2024 an onsite registration can be changed to online and vice versa, at no additional charge.

Registration fees and deadlines

Individual registration will remain open for the duration of the congress. The ESMO Congress Secretariat must receive one completed registration per participant and the corresponding payment in EUR by the given deadlines.

ESMO membership must be active seven (7) days prior to the registration deadline for the reduced member registration fee to be applied. Please visit the membership page to check eligibility criteria, benefits, and to complete the membership application. 

Registration fees for onsite and online participation
(21% Czech VAT included)

Early registration
until 17 January 2024

Late registration
until 21 February 2024

Full registration
from 22 February 2024

ESMO / IASLC / ESTS / ESTRO Member

€ 330.00

€ 463.00

€ 700.00

ESMO / IASLC / ESTS / ESTRO Developing Countries*

€ 82.00

€ 107.00

€ 158.00

ESMO / IASLC / ESTS / ESTRO Member in training**

€ 82.00

€ 107.00

€ 158.00

ESMO Undergraduate student

€ 82.00

€ 107.00

€ 158.00

ESMO Nurse

€ 82.00

€ 107.00

€ 158.00

ESMO Patient Advocate

€ 82.00

€ 107.00

€ 158.00

Non-Member

€ 556.00

€ 782.00

€ 926.00

* Applicable to ESMO/IASLC/ESTS/ESTRO Members from developing countries only. At the time of application, developing countries are defined by ESMO according to the World Bank classification of low, lower-middle and upper-middle countries based on the Gross National Income (GNI) per capita. Download the PDF outlining which countries are eligible for the discounted registration fees.
** ESMO/IASLC/ESTS/ESTRO Members must be under 40 and in training to qualify for this fee

Confirmation

By the beginning of March 2024 delegates will receive the registration confirmation email and instructions on how to access the European Lung Cancer Congress 2024.

 

 

◆ 参会对象:肿瘤科医师、放射(肿瘤)科医师,胸外科医师,呼吸内科医师,介入放射科医师,病理科医师,护士以及从事肿瘤护理与研究的其他相关专业人士等。

 
 
※相关服务※
会议注册服务:30美金起/人/次(服务费)+ 会议注册费(按官方规定收取,注册类别请咨询客服);
出境签证服务:1650元人民币/人/次(美国,含签证费),其它国家咨询客服;
大会投稿服务:30美金/人/次,官方收取费用另计(如有);
会员申请服务:30-100美金/人/次;

团组参会、行程定制,以及需要其它服务(如接送机等),请直接联系客服。


 
咨询报名:
李老师
400-089-1003(微信扫描右侧二维码咨询)
 
 
领域国际医学会议网——专注专业的国际医学会议服务商,专业服务医学相关群体!
 
  领域国际医学会议网介绍/联系  
版权所有:领域国际医学会议网 未经许可禁止复制转载摘录镜像本站任何内容! 隐私政策/版权/免责声明 | 联系我们